Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $273,564 - $465,976
-1,431 Reduced 29.81%
3,370 $1.1 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $4.12 Million - $5.51 Million
-25,563 Reduced 84.19%
4,801 $914,000
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $9.89 Million - $14.5 Million
-50,891 Reduced 62.63%
30,364 $6.05 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $17.8 Million - $24.2 Million
79,900 Added 5896.68%
81,255 $23.2 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $1.52 Million - $1.89 Million
-8,687 Reduced 86.51%
1,355 $293,000
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $2.05 Million - $2.98 Million
10,042 New
10,042 $2.06 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $436,632 - $807,946
-3,767 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $7.71 Million - $12.5 Million
-60,229 Reduced 94.11%
3,767 $781,000
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $159,845 - $234,091
-968 Reduced 1.49%
63,996 $11.4 Million
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $750,910 - $1.08 Million
-4,579 Reduced 6.58%
64,964 $13.4 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $4.77 Million - $7.32 Million
-36,311 Reduced 34.3%
69,543 $13.2 Million
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $364,521 - $558,398
3,931 Added 3.86%
105,854 $13.8 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $5.99 Million - $9.2 Million
88,747 Added 673.55%
101,923 $10.6 Million
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $563,801 - $998,740
13,176 New
13,176 $999,000
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $397,468 - $693,272
-14,586 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$23.16 - $47.74 $337,811 - $696,335
14,586 New
14,586 $484,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.